BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
4.080
-0.245 (-5.66%)
May 27, 2026, 12:20 PM CET
Market Cap371.36M +13.8%
Revenue (ttm)282.52M +36.0%
Net Income3.39M
EPS0.04
Shares Out 85.86M
PE Ratio109.49
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume287,172
Open4.160
Previous Close4.325
Day's Range3.990 - 4.160
52-Week Range3.650 - 4.700
Beta0.16
Analystsn/a
Price Targetn/a
Earnings DateApr 29, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements